— Know what they know.
Not Investment Advice
Also trades as: 0IJO.L (LSE) · $vol 0M · EX9.DE (XETRA) · $vol 0M

EXEL NASDAQ

Exelixis, Inc.
1W: +1.5% 1M: +12.0% 3M: +18.1% YTD: +50.0% 1Y: +68.8% 3Y: +209.6% 5Y: +203.9%
$65.35
+0.24 (+0.37%)
 
Weekly Expected Move ±2.7%
$61 $63 $65 $66 $68
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Buy · Power 70 · $16.4B mcap · 214M float · 1.16% daily turnover · Short 56% of daily vol
Credit Risk of going bust: lower than 92% of companies Debt: 1.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.05 (down 99.9%), Exelixis, Inc. would be worth roughly what it owes.
Total debt $165.9M against a stock market value of $16.43B.
Distance to default 15.71 (Merton model): prices to 2026-10-27, balance sheet 2026-07-03, debt counted $83.0M (short-term plus half of long-term), stock volatility 33.8%; Altman Z'' 7.72. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$2.8B -3.5% ▼
5Y CAGR: +5.9%
Total Liabilities
$683M -2.9% ▼
5Y CAGR: +21.5%
Shareholders Equity
$2.2B -3.7% ▼
5Y CAGR: +2.8%
Cash & Investments
$1.1B -4.7% ▼
5Y CAGR: -2.6%
Total Debt
$173M -9.3% ▼
5Y CAGR: +28.7%
Net Debt
-$309M -1065.5% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$647M$501M$263M$217M$482M
Short-Term Investments$820M$807M$732M$894M$577M
Cash & ST Investments$1.5B$1.3B$995M$1.1B$1.1B
Net Receivables$283M$215M$237M$265M$287M
Inventory$27M$33M$17M$22M$22M
Other Current Assets$0$62M$68M$68M$76M
Total Current Assets$1.8B$1.6B$1.3B$1.5B$1.4B
Property, Plant & Equip.$104M$345M$471M$359M$441M
Goodwill & Intangibles$64M$64M$64M$64M$64M
Long-Term Investments$371M$757M$729M$637M$604M
Other Non-Current Assets$131M$56M$0$0$0
Total Non-Current Assets$781M$1.5B$1.6B$1.5B$1.4B
Total Assets$2.6B$3.1B$2.9B$2.9B$2.8B
— Liabilities —
Accounts Payable$24M$33M$34M$38M$30M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$8M$7M$0$0$0
Other Current Liabilities$46M$71M$82M$267M$287M
Total Current Liabilities$338M$324M$394M$404M$406M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$8M$62M$94M$109M$104M
Total Non-Current Liabilities$68M$259M$284M$300M$277M
Total Liabilities$406M$583M$678M$703M$683M
— Equity —
Common Stock$319K$324K$303K$282K$262K
Retained Earnings-$217M-$34M-$173M-$99M-$77M
Accumulated OCI-$758K-$15M-$4M-$1M$3M
Total Stockholders Equity$2.2B$2.5B$2.3B$2.2B$2.2B
Total Liabilities & Equity$2.6B$3.1B$2.9B$2.9B$2.8B
— Key Metrics —
Total Debt$51M$190M$190M$191M$173M
Net Debt-$596M-$311M-$73M-$27M-$309M
Total Investments$1.2B$1.6B$1.5B$1.5B$1.2B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms